Bio-Path Holdings, Inc. (OTCPK: BPTH)
Health Care · Biotechnology · US
$0.00
+50.00% today · -99.6% 1Y
Bio-Path Holdings, Inc. (OTCPK: BPTH) operates in the Biotechnology industry within the Health Care sector. The company is valued at $16.17K and employs 1 people.
Over the last twelve months the share price has lost 99.6%, trading between 0.00 and 0.11.
Tweenvest scores Bio-Path Holdings, Inc. across four factors: quality 17/100, value 37/100. Its strongest factor is value.
BPTH price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $16.17K
- Revenue (TTM)
- —
- P/E
- —
- EPS
- -0.30
- Dividend yield
- —
- Beta (5Y)
- -0.43
- 52-week high
- $0.11
- 52-week low
- $0.00
- Avg volume (3M)
- —
- Shares outstanding
- 53.90M
- Employees
- 1
- Next earnings
- —
About Bio-Path Holdings, Inc.
Bio-Path Holdings, Inc. is a U.S.-based pharmaceutical company focused on developing RNAi nanoparticle drugs for oncology, with programs spanning both clinical and preclinical stages. Its innovative product development is centered around the DNAbilize platform, a drug delivery and antisense technology that employs a P-ethoxy modified deoxyribonucleic acid (DNA) backbone. This modification is specifically engineered to shield the DNA from premature degradation. The company's lead drug candidate, prexigebersen, is presently in Phase II clinical trials for the treatment of acute myeloid leukemia (AML) and myelodysplastic syndrome. Additionally, Bio-Path is advancing Liposomal Bcl-2 for refractory/relapsed lymphoma and chronic lymphocytic leukemia. Another promising asset, Liposomal STAT3, is in preclinical development, targeting pancreatic cancer, non-small cell lung cancer, and AML. Furthermore, prexigebersen-A is under development for various solid tumors. Bio-Path Holdings, Inc., founded in 2007, is headquartered in Bellaire, Texas.
- ISIN
- US09057N4097
- Founded
- 2007
- Listed since
- Mar 4, 2008
- Exchange
- Pink Sheets LLC
- Currency
- USD
Other Biotechnology companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Dragon Life Science Holdings Group, Inc.OTCPK: NOHO | $20.04K | $0.00 | — |
| T2 Biosystems, Inc.OTCPK: TTOO | $19.63K | $0.00 | +16.67% |
| Neovacs S.A.ENXTPA: ALNEV | $17.12K | €0.10 | -3.90% |
| Scopus BioPharma Inc.OTCPK: SCPS | $16.83K | $0.00 | -33.33% |
| CardioGenics Holdings IncOTCPK: CGNH | $14.29K | $0.00 | — |
| Vaxxinity, Inc.OTCPK: VAXX | $12.68K | $0.00 | -99.60% |
| ObsEva SAOTCPK: OBSE.F | $11.72K | $0.00 | +9900.00% |
| Syros Pharmaceuticals, Inc.OTCPK: SYRS | $10.73K | $0.00 | -96.67% |
Figures last refreshed Oct 18, 2026.